Aventis Pharma S.A.
Records under this name other than the patents Aventis Pharma S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 10 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,608,961 | Method for Affinity Chromatography of Antithrombin III now held by Sanofi Mature IP In force · High confidence | In force | High confidence | |
| US 8,211,676 | Cholesterol-Producing Yeast Strains and Uses Thereof now held by Euroapi France In force · High confidence | In force | High confidence | |
| US 8,927,592 | Novel Antitumoral Use of Cabazitaxel now held by Sanofi Mature IP In force · Medium confidence | In force | Medium confidence | |
| US 10,583,110 | Novel Antitumoral Use of Cabazitaxel now held by Sanofi Mature IP In force · High confidence | In force | High confidence | |
| US 10,716,777 | Novel Antitumoral Use of Cabazitaxel now held by Sanofi Mature IP In force · Medium confidence | In force | Medium confidence | |
| US 7,612,087 | Heterocyclic Compounds as Inhibitors of Beta-Lactamases now held by Allergan Pharmaceuticals International Limited Term ended Term ended Nov 12, 2026 · High confidence | Term ended | Term ended Nov 12, 2026 | High confidence |
| US 8,846,959 | Crystalline Forms of Dimethoxy Docetaxel and Methods for Preparing the Same Lapsed on the fee record Ended Sep 30, 2026 · Medium confidence | Lapsed on the fee record | Ended Sep 30, 2026 | Medium confidence |
| US 7,449,572 | Process and Intermediates for Preparing 17-Halogenated 19-Norsteroid Compounds Term ended Term ended Aug 15, 2026 · High confidence | Term ended | Term ended Aug 15, 2026 | High confidence |
| US 7,575,930 | Method for Analyzing Oligosaccharides from Blood Plasma Term ended Term ended Jan 18, 2026 · High confidence | Term ended | Term ended Jan 18, 2026 | High confidence |
| US 7,112,592 | Azabicyclic Compounds, Preparation Thereof and Use as Medicines, in Particular as Antibacterial Agents now held by Allergan Pharmaceuticals International Limited Term ended Term ended Jan 7, 2026 · High confidence | Term ended | Term ended Jan 7, 2026 | High confidence |